πŸ‡ΊπŸ‡Έ FDA
Patent

US 9441022

Aegyptin and uses thereof

granted A61KA61K38/00A61K38/49

Quick answer

US patent 9441022 (Aegyptin and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00, A61K38/49, A61K39/0003, A61K45/06